unknown
Stage
1
Investors
About
Exin Therapeutics uses AI-trained multimodal models and high-throughput in‑house mouse studies to discover therapeutics that modulate neural activity. Its initial programs target epilepsies associated with autism and Parkinson’s disease.
Explore Exin Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.